OmniActive Initiates Patent Infringement Suit Against Bio-gen to Protect Innovations in Health Solutions

OmniActive Files Patent Infringement Lawsuit Against Bio-gen

OmniActive Health Technologies Ltd., a frontrunner in health solutions backed by scientific research, recently announced the filing of a patent infringement lawsuit against Bio-gen Extracts Pvt. Ltd. This legal action took place on June 23, 2025, in the United States District Court for the Eastern District of Texas. The lawsuit aims to assert OmniActive's intellectual property rights associated with U.S. Patent No. 10,532,035, commonly referred to as the '035 Patent.

The crux of the lawsuit centers around OmniActive's claim that Bio-gen has been infringing upon its patent through unauthorized commercial activities related to its Lute-gen® product. The '035 Patent represents a significant advancement in promoting visual health through naturally sourced compounds. Specifically, it outlines the methods of enhancing visual function through the application of marigold-derived lutein and zeaxanthin isomers, administered in precise quantities and proportions.

The coveted '035 Patent methods are integral to Lutemax 2020, OmniActive's flagship ingredient, which has garnered recognition in the industry for its clinical benefits. Lutemax 2020 uniquely combines lutein and zeaxanthin isomers to support eye health, making it a versatile ingredient for various applications in dietary supplements, foods, and beverages aimed at enhancing health and performance.

As a proactive measure, OmniActive is committed to safeguarding its intellectual property. The company’s lawsuit does not just seek compensation; it also calls for a jury trial against Bio-gen, claiming damages, legal costs, and a determination of willful infringement. Moreover, OmniActive is pursuing an injunction to prevent Bio-gen from continuing any infringing activities.

This legal maneuver illustrates OmniActive's unwavering determination to protect its groundbreaking technologies and ensure that it can continue delivering innovative wellness solutions that provide its clients with a competitive market advantage. The commitment to preserving its intellectual property is a testament to OmniActive's mission of advancing health through nature-inspired science.

In summary, the legal battle with Bio-gen underscores the importance of protecting proprietary innovations in the competitive landscape of health and wellness. OmniActive's actions are aimed at maintaining its position as a leader in the industry, committed to scientific progress and customer empowerment through high-quality products.

For more information on OmniActive and its range of health solutions, visit omniactives.com.

About OmniActive

Founded in 2005, OmniActive Health Technologies specializes in life-enhancing health solutions derived from natural sources. The company’s product offerings feature scientifically validated, IP-protected Specialty Actives as well as a comprehensive array of natural Botanical Actives, catering to global clients in the dietary supplement and functional food sectors. With corporate offices situated in both Mumbai, India, and Bridgewater, New Jersey, OmniActive continues to expand its influence in the health market.